InsidersTradesSigma
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the full record of transactions filed by Davis Gregory D. Officer active across 1 company, notably Sangamo Therapeutics, INC. Cumulatively, 5 disclosures have been recorded. History available since 24 November 2024. The latest transaction was filed on 25 May 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
5 of 5 declarations